Our Members
As a member-focused Association, our members are at the heart of everything we do at the PRI.
In principle any organization (public or private) is eligible to join the Association and become part of Europe’s growing microbiome-based medicinal product ecosystem.
Find out more about the different ways you and your organization can get involved with the PRI’s activities.
- Microbiome Regulatory Science Support Work
- Pre-competitive Task Groups
- Year-round networking and project-related communication support
PRI Members represent nearly every point along the microbiome science and development continuum, from fundamental research groups all the way to commercial manufacturing partners and pharmaceutical companies.
ProDigest BV
Massimo Marzorati
CEO
The most complete in vitro technology platform (from high-throughput to detailed MoA) to assess the fate of Microbiome-based medicinal products along the GI tract.
PROGE FARM S.r.l.
Antonella Bonetti
Regulatory Affairs Manager
PROGE FARM develops, produces, registers (even as medicine) and put on the markets, directly or through licensees, its products based on selected patented probiotic strains.
Quadram Institute
Graeme Brown
CBO
At the forefront of research into food, the gut microbiome, and human health, the Quadram is a unique partnership between Quadram Institute Bioscience, the Norfolk and Norwich University Hospitals NHS Foundation Trust and the University of East Anglia (UEA).
Sanofi Consumer Healthcare
Martina Nittel
Global Regulatory Lead for Probiotics
Seventure Partners
Isabelle de Cremoux
CEO & Managing Partner
Seventure Partners finances the development of innovative companies within Life sciences and Digital technologies. We have 20 years of experience which has enabled Seventure to acquire expertise and networks in these two fields which services the needs of entrepreneurs.
Siolta Therapeutics
Nikole Kimes
CEO & Founder
Siolta Therapeutics is a clinical-stage biotech company on a mission to alleviate the suffering of millions impacted by chronic inflammatory diseases through novel microbiome-based medicines.
Spanish National Research Council (IATA-CSIC)
Yolanda Sanz
Full Professor
Microbiome, Intestinal Human Bacteria, Immunity, Body-Brain Interactions, Diet, Obesity, Diabetes, Cardiovascular Disease, Mood, Comorbidities, Microbiome-Based Diagnosis, Prevention and Therapy, Microbiome-Directed Nutrition.
Starfish Bioscience
Sandrine Claus
Founder & CEO
STARFISH Bioscience specializes in the innovation and development of microbiological solutions for agriculture and viticulture.
Our mission is to regenerate soils through the restoration of their microbiomes to improve sustainability and productivity, while minimizing environmental impact.
We are committed to contributing to the well-being of humanity and the preservation of the planet, by developing technologies that meet the future challenges of global agriculture.
